Loading...
Please wait, while we are loading the content...
Similar Documents
Nanoparticles as Drug Delivery Systems of RNAi in Cancer Therapy
| Content Provider | MDPI |
|---|---|
| Author | Li, Die Die Gao, Chengzhi Kuang, Meiyan Xu, Minhao Wang, Ben Luo, Yi Teng, Lesheng Xie, Jing |
| Copyright Year | 2021 |
| Description | RNA interference (RNAi) can mediate gene-silencing by knocking down the expression of a target gene via cellular machinery with much higher efficiency in contrast to other antisense-based approaches which represents an emerging therapeutic strategy for combating cancer. Distinct characters of nanoparticles, such as distinctive size, are fundamental for the efficient delivery of RNAi therapeutics, allowing for higher targeting and safety. In this review, we present the mechanism of RNAi and briefly describe the hurdles and concerns of RNAi as a cancer treatment approach in systemic delivery. Furthermore, the current nanovectors for effective tumor delivery of RNAi therapeutics are classified, and the characteristics of different nanocarriers are summarized. |
| Starting Page | 2380 |
| e-ISSN | 14203049 |
| DOI | 10.3390/molecules26082380 |
| Journal | Molecules |
| Issue Number | 8 |
| Volume Number | 26 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2021-04-19 |
| Access Restriction | Open |
| Subject Keyword | Molecules Biomedical Engineering Pharmacology and Pharmacy Nanoparticles Rna Interference Cancer |
| Content Type | Text |
| Resource Type | Article |